Synlett 2019; 30(08): 977-981
DOI: 10.1055/s-0037-1611806
letter
© Georg Thieme Verlag Stuttgart · New York

Concise Stereocontrolled Synthesis of an α-Carbagalactose Segment of RCAI-56, a Candidate Anticancer Agent

Naoki Ushida
,
Nobukazu Nagai
,
,
Toshio Nishikawa*
Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya 464-8601, Japan   Email: nisikawa@agr.nagoya-u.ac.jp
› Author Affiliations

This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 16H04915), Grants-in-Aid for Scientific Research on Innovative Areas ‘Frontier Research on Chemical Communications’ (No.17H06406), and ‘Middle Molecular Strategy’ (No.18H04400) from MEXT.
Further Information

Publication History

Received: 05 March 2019

Accepted after revision: 01 April 2019

Publication Date:
11 April 2019 (online)


Preview

Abstract

RCAI-56 is a synthetic glycolipid exhibiting a potent antitumor activity by stimulation of natural killer T cells. Tetra-O-benzyl-α-carbagalactose, an important synthetic segment of RCAI-56, was stereoselectively synthesized from 1,4-dichloro-2-butene in nine steps, including the key step of organocatalytic asymmetric Diels–Alder reaction between acrolein and 1-benzyloxybutadiene.

Supporting Information